Effective and enduring surgical treatment for targeted therapy-related paronychia: A retrospective study

The development of targeted therapy has improved treatment outcomes for patients with non-small cell lung cancer (NSCLC). However, paronychia, a common adverse effect of targeted therapy, remains burdensome. Although conservative treatments for paronychia have been well reported in the literature, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting-Hsuan, Wu, Shu-Yu, Tsai, Sheng-Lin, Wu, Chien-Wei, Hou, Chih-Chun, Lai, Chung-Yu, Tzeng, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4000
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592431/
https://www.ncbi.nlm.nih.gov/pubmed/36281135
http://dx.doi.org/10.1097/MD.0000000000031208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592431/
https://www.ncbi.nlm.nih.gov/pubmed/36281135
http://dx.doi.org/10.1097/MD.0000000000031208

Ejemplares similares